Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels

Paul B. Fitzgerald, Shitij Kapur, Gary Remington, Paul Roy, Robert B. Zipursky

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Positron emission tomography (PET) is increasingly being used to study dopamine receptor occupancy and the clinical effects of antipsychotic medication. Dopamine D2 receptor occupancy has been shown to predict several clinical effects of antipsychotic medication including therapeutic response, motor and endocrine side-effects. Plasma levels may be used as a surrogate marker for central occupancy if the relationship between these two measures may be accurately described. This study was designed to test the capacity of a previously derived relationship equation (%D2 occupancy=plasma level/ED50+plasma level, where ED50=0.40 ng/ml) to predict striatal D2 occupancy from plasma level. Twenty-one patients receiving treatment with low dose haloperidol underwent a 11C-raclopride PET scan to measure D2 occupancy. The D2 occupancy levels were accurately predicted by use of the previously generated equation with only a small degree of error (3.89% CI 0.45-7.33). Predicted and measured D2 occupancy values correlated closely (Pearson's r=0.864, P=0.003). The study indicates that reliable prediction of D2 occupancy from plasma levels is possible. This provides a potentially useful surrogate measure of D2 occupancy for research and possibly clinical practice, as the routine use of PET to measure occupancy levels is not feasible.

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalPsychopharmacology
Volume149
Issue number1
DOIs
Publication statusPublished - 1 Jan 2000
Externally publishedYes

Keywords

  • Dopamine
  • Haloperidol
  • Human
  • Receptor occupancy

Cite this

Fitzgerald, Paul B. ; Kapur, Shitij ; Remington, Gary ; Roy, Paul ; Zipursky, Robert B. / Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels. In: Psychopharmacology. 2000 ; Vol. 149, No. 1. pp. 1-5.
@article{a3c0efcd0dc34e78b78250d0b0171390,
title = "Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels",
abstract = "Positron emission tomography (PET) is increasingly being used to study dopamine receptor occupancy and the clinical effects of antipsychotic medication. Dopamine D2 receptor occupancy has been shown to predict several clinical effects of antipsychotic medication including therapeutic response, motor and endocrine side-effects. Plasma levels may be used as a surrogate marker for central occupancy if the relationship between these two measures may be accurately described. This study was designed to test the capacity of a previously derived relationship equation ({\%}D2 occupancy=plasma level/ED50+plasma level, where ED50=0.40 ng/ml) to predict striatal D2 occupancy from plasma level. Twenty-one patients receiving treatment with low dose haloperidol underwent a 11C-raclopride PET scan to measure D2 occupancy. The D2 occupancy levels were accurately predicted by use of the previously generated equation with only a small degree of error (3.89{\%} CI 0.45-7.33). Predicted and measured D2 occupancy values correlated closely (Pearson's r=0.864, P=0.003). The study indicates that reliable prediction of D2 occupancy from plasma levels is possible. This provides a potentially useful surrogate measure of D2 occupancy for research and possibly clinical practice, as the routine use of PET to measure occupancy levels is not feasible.",
keywords = "Dopamine, Haloperidol, Human, Receptor occupancy",
author = "Fitzgerald, {Paul B.} and Shitij Kapur and Gary Remington and Paul Roy and Zipursky, {Robert B.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1007/s002139900333",
language = "English",
volume = "149",
pages = "1--5",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer-Verlag London Ltd.",
number = "1",

}

Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels. / Fitzgerald, Paul B.; Kapur, Shitij; Remington, Gary; Roy, Paul; Zipursky, Robert B.

In: Psychopharmacology, Vol. 149, No. 1, 01.01.2000, p. 1-5.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels

AU - Fitzgerald, Paul B.

AU - Kapur, Shitij

AU - Remington, Gary

AU - Roy, Paul

AU - Zipursky, Robert B.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Positron emission tomography (PET) is increasingly being used to study dopamine receptor occupancy and the clinical effects of antipsychotic medication. Dopamine D2 receptor occupancy has been shown to predict several clinical effects of antipsychotic medication including therapeutic response, motor and endocrine side-effects. Plasma levels may be used as a surrogate marker for central occupancy if the relationship between these two measures may be accurately described. This study was designed to test the capacity of a previously derived relationship equation (%D2 occupancy=plasma level/ED50+plasma level, where ED50=0.40 ng/ml) to predict striatal D2 occupancy from plasma level. Twenty-one patients receiving treatment with low dose haloperidol underwent a 11C-raclopride PET scan to measure D2 occupancy. The D2 occupancy levels were accurately predicted by use of the previously generated equation with only a small degree of error (3.89% CI 0.45-7.33). Predicted and measured D2 occupancy values correlated closely (Pearson's r=0.864, P=0.003). The study indicates that reliable prediction of D2 occupancy from plasma levels is possible. This provides a potentially useful surrogate measure of D2 occupancy for research and possibly clinical practice, as the routine use of PET to measure occupancy levels is not feasible.

AB - Positron emission tomography (PET) is increasingly being used to study dopamine receptor occupancy and the clinical effects of antipsychotic medication. Dopamine D2 receptor occupancy has been shown to predict several clinical effects of antipsychotic medication including therapeutic response, motor and endocrine side-effects. Plasma levels may be used as a surrogate marker for central occupancy if the relationship between these two measures may be accurately described. This study was designed to test the capacity of a previously derived relationship equation (%D2 occupancy=plasma level/ED50+plasma level, where ED50=0.40 ng/ml) to predict striatal D2 occupancy from plasma level. Twenty-one patients receiving treatment with low dose haloperidol underwent a 11C-raclopride PET scan to measure D2 occupancy. The D2 occupancy levels were accurately predicted by use of the previously generated equation with only a small degree of error (3.89% CI 0.45-7.33). Predicted and measured D2 occupancy values correlated closely (Pearson's r=0.864, P=0.003). The study indicates that reliable prediction of D2 occupancy from plasma levels is possible. This provides a potentially useful surrogate measure of D2 occupancy for research and possibly clinical practice, as the routine use of PET to measure occupancy levels is not feasible.

KW - Dopamine

KW - Haloperidol

KW - Human

KW - Receptor occupancy

UR - http://www.scopus.com/inward/record.url?scp=0034126828&partnerID=8YFLogxK

U2 - 10.1007/s002139900333

DO - 10.1007/s002139900333

M3 - Article

VL - 149

SP - 1

EP - 5

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -